11-6396197-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS2_Supporting
The NM_001164.5(APBB1):c.1691G>A(p.Gly564Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000709 in 1,550,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APBB1 | NM_001164.5 | c.1691G>A | p.Gly564Glu | missense_variant | 13/15 | ENST00000609360.6 | NP_001155.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
APBB1 | ENST00000609360.6 | c.1691G>A | p.Gly564Glu | missense_variant | 13/15 | 5 | NM_001164.5 | ENSP00000477213 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000252 AC: 4AN: 158572Hom.: 0 AF XY: 0.0000240 AC XY: 2AN XY: 83190
GnomAD4 exome AF: 0.00000572 AC: 8AN: 1398770Hom.: 0 Cov.: 32 AF XY: 0.00000725 AC XY: 5AN XY: 689956
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.1691G>A (p.G564E) alteration is located in exon 13 (coding exon 12) of the APBB1 gene. This alteration results from a G to A substitution at nucleotide position 1691, causing the glycine (G) at amino acid position 564 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at